Conditions: Lymphoma, Large-Cell, Diffuse
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 81
Healthy volunteers: no

Brief summary:
The purpose of this trial is to determine the effect of ofatumumab in patients with Diffused Large B-Cell Lymphoma (DLBCL) ineligible for transplant or relapsed after autologous transplant

Detailed description:

Arms:
arm 1: 8 weekly intra-venous (I.V.) infusions, 1 x 300mg and 7 x 1000mg

Interventions: intervention 1: Ofatumumab
Intervention descriptions: intervention 1: 8 weekly intra-venous (i.v.) infusions, 1 x 300mg and 7 x 1000mg

Protocol document: